<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01012843</url>
  </required_header>
  <id_info>
    <org_study_id>AUTF-001</org_study_id>
    <nct_id>NCT01012843</nct_id>
  </id_info>
  <brief_title>Do Antibiotics Prevent Anal Fistulae Formation?</brief_title>
  <official_title>Does Adjuvant Antibiotic Treatment After Drainage of Anorectal Abscess Prevent the Development of Anal Fistulae? A Prospective Randomized, Placebo Controlled, Double Blind, Multi-Center Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: This randomized study assesses the effects of antibiotics on the formation of
      fistulae after drainage of anorectal abscesses.

      Methods: Patients who underwent abscess drainage in 3 major colorectal units between
      September 2005 and January 2008 were included. Previous anorectal surgery history,
      immunecompromised states, pregnancy, inflammatory bowel disease, antibiotic usage prior to
      surgery and the presence of an anal fistulae at the time of surgery were the exclusion
      criteria. Patients were randomized and given either placebo or amoxicillin-clavulanic acid
      combination treatment for 10 days. Patients were followed one year for perianal fistulae
      formation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fistula formation</measure>
    <time_frame>1 year after surgery</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">151</enrollment>
  <condition>Anal Fistula</condition>
  <arm_group>
    <arm_group_label>Antibiotic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who received antibiotic treatment after abscess drainage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients who received placebo after abscess drainage</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin-Clavulanate</intervention_name>
    <description>oral 875/125 mg tablets of Amoxicillin/Clavulanate 2 times a day for 10 days</description>
    <arm_group_label>Antibiotic</arm_group_label>
    <other_name>Bioment 1 gr BID tablets</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>oral Placebo tablets two times a day for 10 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Presence of anorectal abscess

        Exclusion Criteria:

          -  Allergy to penicillin derivatives

          -  Treatment with any antimicrobial agent in the week before enrolment

          -  Recognized other infection at the time of surgery

          -  Previous anorectal surgery

          -  Presence of inflammatory bowel disease

          -  Suspicion of Fournier's gangrene

          -  Secondary and recurrent anorectal abscesses

          -  Presence of an internal opening

          -  Any additional surgical procedure performed in the same session or during follow-up

          -  Antibiotic prophylaxis indicated for another reason

          -  Immunosuppressive and/or anticoagulant drug treatment being taken at the time of
             surgery

          -  Diabetes mellitus

          -  Known chronic disabling disease

          -  Pregnancy

          -  Lactation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulas Sozener, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Ankara University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ankara Numune Teaching and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ankara University School of Medicine Department Of General Surgery</name>
      <address>
        <city>Ankara</city>
        <zip>06100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dicle University School of Medicine</name>
      <address>
        <city>Diyarbakir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Vasilevsky CA, Gordon PH. The incidence of recurrent abscesses or fistula-in-ano following anorectal suppuration. Dis Colon Rectum. 1984 Feb;27(2):126-30.</citation>
    <PMID>6697831</PMID>
  </reference>
  <results_reference>
    <citation>Nunoo-Mensah JW, Balasubramaniam S, Wasserberg N, Artinyan A, Gonzalez-Ruiz C, Kaiser AM, Beart RW Jr, Vukasin P. Fistula-in-ano: do antibiotics make a difference? Int J Colorectal Dis. 2006 Jul;21(5):441-3. Epub 2005 Aug 10.</citation>
    <PMID>16091913</PMID>
  </results_reference>
  <results_reference>
    <citation>Hämäläinen KP, Sainio AP. Incidence of fistulas after drainage of acute anorectal abscesses. Dis Colon Rectum. 1998 Nov;41(11):1357-61; discussion 1361-2.</citation>
    <PMID>9823799</PMID>
  </results_reference>
  <results_reference>
    <citation>Ramanujam PS, Prasad ML, Abcarian H, Tan AB. Perianal abscesses and fistulas. A study of 1023 patients. Dis Colon Rectum. 1984 Sep;27(9):593-7.</citation>
    <PMID>6468199</PMID>
  </results_reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2009</study_first_submitted>
  <study_first_submitted_qc>November 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2009</study_first_posted>
  <last_update_submitted>November 13, 2009</last_update_submitted>
  <last_update_submitted_qc>November 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr. Ulas Sozener</name_title>
    <organization>Ankara University School of Medicine Department of General Surgery</organization>
  </responsible_party>
  <keyword>Perianal</keyword>
  <keyword>Abscess</keyword>
  <keyword>Fistulae in ano</keyword>
  <keyword>Antibiotic</keyword>
  <keyword>Anorectal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Rectal Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Clavulanic Acid</mesh_term>
    <mesh_term>Clavulanic Acids</mesh_term>
    <mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 16, 2009</submitted>
    <returned>December 22, 2009</returned>
    <submitted>December 23, 2009</submitted>
    <returned>January 26, 2010</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

